Spire Wealth Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.4K | Hold |
2,645
| – | – | ﹤0.01% | 1444 |
|
|
2025
Q1 | $22.7K | Hold |
2,645
| – | – | ﹤0.01% | 1568 |
|
|
2024
Q4 | $28.4K | Hold |
2,645
| – | – | ﹤0.01% | 1499 |
|
|
2024
Q3 | $15K | Hold |
2,645
| – | – | ﹤0.01% | 1525 |
|
|
2024
Q2 | $11.2K | Hold |
2,645
| – | – | ﹤0.01% | 1609 |
|
|
2024
Q1 | $13.5K | Hold |
2,645
| – | – | ﹤0.01% | 1627 |
|
|
2023
Q4 | $16K | Hold |
2,645
| – | – | ﹤0.01% | 1605 |
|
|
2023
Q3 | $17.3K | Hold |
2,645
| – | – | ﹤0.01% | 1557 |
|
|
2023
Q2 | $21.5K | Hold |
2,645
| – | – | ﹤0.01% | 1569 |
|
|
2023
Q1 | $22.7K | Hold |
2,645
| – | – | ﹤0.01% | 1573 |
|
|
2022
Q4 | $24K | Hold |
2,645
| – | – | ﹤0.01% | 1293 |
|
|
2022
Q3 | $27K | Hold |
2,645
| – | – | ﹤0.01% | 1198 |
|
|
2022
Q2 | $26K | Hold |
2,645
| – | – | ﹤0.01% | 1550 |
|
|
2022
Q1 | $33K | Hold |
2,645
| – | – | ﹤0.01% | 1609 |
|
|
2021
Q4 | $46K | Sell |
2,645
-150
| -5% | -$2.61K | ﹤0.01% | 1772 |
|
|
2021
Q3 | $50K | Buy |
2,795
+150
| +6% | +$2.68K | ﹤0.01% | 1472 |
|
|
2021
Q2 | $60K | Sell |
2,645
-325
| -11% | -$7.37K | ﹤0.01% | 1401 |
|
|
2021
Q1 | $44K | Buy |
+2,970
| New | +$44K | ﹤0.01% | 1782 |
|